Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease

Brain

Volumn 138, Issue 12, 2015, Pages 3716-3733

  Kimbrough, Ian F ^a,b   Robel, Stefanie ^a,b   Roberson, Erik D ^a,c,d,e   Sontheimer, Harald ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NONE   (United States)

Author keywords

Alzheimer's disease; amyloidosis; multi photon imaging; neurovascular coupling; vascular amyloid

Indexed keywords

AMYLOID; CALCIUM; CALCIUM ION; DYE; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; BRAIN REGION; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; GLIOVASCULAR UNIT; IMAGING; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE CELL; AMYLOID PLAQUE; AMYLOIDOSIS; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; HUMAN; MALE; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; ASTROCYTES; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; PLAQUE, AMYLOID;

EID: 84951097605     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv327     Document Type: Article

References (69)

1. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010; 468: 232-43.
2. Blanco VM, Stern JE, Filosa JA. Tone-dependent vascular responses to astrocyte-derived signals. Am J Physiol Heart Circ Physiol 2008; 294: H2855-63.
3. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimers disease. N Engl J Med 2000; 343: 450-6.
4. Bragg AD, Amiry-Moghaddam M, Ottersen OP, Adams ME, Froehner SC. Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on alpha-syntrophin. Glia 2006; 53: 879-90.
5. Choi M, Yoon J, Choi C. Label-free optical control of arterial contraction. J Biomed Opt 2010; 15: 015006.
6. Crawford F, Suo Z, Fang C, Sawar A, Su G, Arendash G, et al. The vasoactivity of a beta peptides. Ann N Y Acad Sci 1997; 826: 35-46.
7. Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW, et al. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimers disease. J Neuropathol Exp Neurol 2005; 64: 588-94.
8. Dorn GW II, Becker MW. Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther 1993; 265: 447-56.
9. Dorr A, Sahota B, Chinta LV, Brown ME, Lai AY, Ma K, et al. Amyloid-beta-dependent compromise of microvascular structure and function in a model of Alzheimerss disease. Brain 2012; 135: 3039-50.
10. Edwards R, Trizna W. Response of isolated intracerebral arterioles to endothelins. Pharmacology 1990; 41: 149-52.
11. Eichhoff G, Busche MA, Garaschuk O. In vivo calcium imaging of the aging and diseased brain. Eur J Nucl Med Mol Imaging 2008; 35: S99-106.
12. Ellis EF, Wei EP, Kontos HA. Vasodilation of cat cerebral arterioles by prostaglandins D2, E2, G2, and I2. Am J Physiol 1979; 237: H381-5.
13. Ellis-Davies GC, Barsotti RJ. Tuning caged calcium: photolabile analogues of EGTA with improved optical and chelation properties. Cell Calcium 2006; 39: 75-83.
14. Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimers disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006; 26: 5167-79.
15. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimers disease. Prog Neurobiol 2001; 64: 575-611.
16. Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT. Astrocytic endfoot Ca2 + and BK channels determine both arteriolar dilation and constriction. Proc Natl Acad Sci USA 2010; 107: 3811-16.
17. Gordon GR, Mulligan SJ, MacVicar BA. Astrocyte control of the cerebrovasculature. Glia 2007; 55: 1214-21.
18. Gotz J, Ittner LM. Animal models of Alzheimerss disease and frontotemporal dementia. Nat Rev Neurosci 2008; 9: 532-44.
19. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995; 32: 79-92.
20. Hirase H, Qian L, Bartho P, Buzsaki G. Calcium dynamics of cortical astrocytic networks in vivo. PLoS Biol 2004; 2: E96.
21. Hoshi A, Yamamoto T, Shimizu K, Ugawa Y, Nishizawa M, Takahashi H, et al. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimers disease. J Neuropathol Exp Neurol 2012; 71: 750-9.
22. Hughes TM, Kuller LH, Barinas-Mitchell EJ, McDade EM, Klunk WE, Cohen AD, et al. Arterial stiffness and beta-amyloid progression in nondemented elderly adults. JAMA Neurol 2014; 71: 562-8.
23. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimerss disease. Nat Rev Neurosci 2004; 5: 347-60.
24. Iadecola C. The pathobiology of vascular dementia. Neuron 2013; 80: 844-66.
25. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007; 10: 1369-76.
26. Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 2014; 34: 16180-93.
27. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 147ra11.
28. Joseph-Mathurin N, Dorieux O, Trouche SG, Boutajangout A, Kraska A, Fontes P, et al. Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds. Neurobiol Aging 2013; 34: 2613-22.
29. Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, et al. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol 2002; 61: 797-805.
30. Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014; 76: 845-61.
31. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimers mice. Science 2009; 323: 1211-15.
32. Lannfelt L, Relkin NR, Siemers ER. Amyloid-ss-directed immunotherapy for Alzheimers disease. J Intern Med 2014; 275: 284-95.
33. Mandybur TI. The incidence of cerebral amyloid angiopathy in Alzheimers disease. Neurol 1975; 25: 120-6.
34. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010; 58: 1094-103.
35. Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM. Vascular betaamyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol 2011; 122: 293-311.
36. Misawa T, Arima K, Mizusawa H, Satoh J. Close association of water channel AQP1 with amyloid-beta deposition in Alzheimers disease brains. Acta Neuropathol 2008; 116: 247-60.
37. Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimers disease. Arch Neurol 2009; 66: 1469-75.
38. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000; 20: 4050-8.
39. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004; 431: 195-9.
40. Nakazawa E, Ishikawa H. Ultrastructural observations of astrocyte end-feet in the rat central nervous system. J Neurocytol 1998; 27: 431-40.
41. Niwa K, Araki E, Morham SG, Ross ME, Iadecola C. Cyclooxygenase-2 contributes to functional hyperemia in whiskerbarrel cortex. J Neurosci 2000; 20: 763-70.
42. Noell S, Wolburg-Buchholz K, Mack AF, Ritz R, Tatagiba M, Beschorner R, et al. Dynamics of expression patterns of AQP4, dystroglycan, agrin and matrix metalloproteinases in human glioblastoma. Cell Tissue Res 2012; 347: 429-41.
43. Park L, Koizumi K, El Jamal S, Zhou P, Previti ML, Van Nostrand WE, et al. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke 2014; 45: 1815-21.
44. Perez E, Barrachina M, Rodriguez A, Torrejon-Escribano B, Boada M, Hernandez I, et al. Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimers disease. Brain Res 2007; 1128: 164-74.
45. Rancillac A, Geoffroy H, Rossier J. Impaired neurovascular coupling in the APPxPS1 mouse model of Alzheimerss disease. Curr Alzheimers Res 2012; 9: 1221-30.
46. Robel S, Berninger B, Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 2011; 12: 88-104.
47. Robel S, Mori T, Zoubaa S, Schlegel J, Sirko S, Faissner A, et al. Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. Glia 2009; 57: 1630-47.
48. Rodriguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A. Astrocytes in physiological aging and Alzheimers disease. Neurosci 2015. Advance Access published on January 14, 2015, doi: 10.1016/j.neuroscience.2015.01.007.
49. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005; 57: 789-94.
50. Shi J, Perry G, Smith MA, Friedland RP. Vascular abnormalities: the insidious pathogenesis of Alzheimers disease. Neurobiol Aging 2000; 21: 357-61.
51. Sirko S, Behrendt G, Johansson PA, Tripathi P, Costa M, Bek S, et al. Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog [corrected]. Cell Stem Cell 2013; 12: 426-39.
52. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimers disease. Neurol 1999; 53: 1391-6.
53. Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 2013; 9: 211-21.
54. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32: 638-47.
55. Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, et al. Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science 2013; 339: 197-200.
56. Takano T, Han X, Deane R, Zlokovic B, Nedergaard M. Two-photon imaging of astrocytic Ca2 + signaling and the microvasculature in experimental mice models of Alzheimers disease. Ann N Y Acad Sci 2007; 1097: 40-50.
57. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006; 9: 260-7.
58. Tang W, Szokol K, Jensen V, Enger R, Trivedi CA, Hvalby O, et al. Stimulation-evoked Ca2 + signals in astrocytic processes at hippocampal CA3-CA1 synapses of adult mice are modulated by glutamate and ATP. J Neurosci 2015; 35: 3016-21.
59. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, et al. An astrocytic basis of epilepsy. Nat Med 2005; 11: 973-81.
60. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987; 18: 311-24.
61. Warth A, Kroger S, Wolburg H. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol 2004; 107: 311-18.
62. Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies GC, Sontheimer H. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 2014; 5: 4196.
63. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimerss disease and their potential impact on therapy. Acta Neuropathol 2009a; 118: 87-102.
64. Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimers disease. Alzheimers Res Ther 2009b; 1: 6.
65. Wolburg H, Noell S, Wolburg-Buchholz K, Mack A, Fallier-Becker P. Agrin, aquaporin-4, and astrocyte polarity as an important feature of the blood-brain barrier. Neuroscientist 2009; 15: 180-93.
66. Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol 2009; 118: 219-33.
67. Yang J, Lunde LK, Nuntagij P, Oguchi T, Camassa LM, Nilsson LN, et al. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimerss disease. J Alzheimers Dis 2011; 27: 711-22.
68. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimerss disease and other disorders. Nat Rev Neurosci 2011; 12: 723-38.
69. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003; 6: 43-50.